Estimating the distribution of nonterminal event time in the presence of mortality or informative dropout

Controlled Clinical Trials

Volumn 24, Issue 2, 2003, Pages 135-146

  Jiang, Hongyu ^a,c   Chappell, Rick ^b   Fine, Jason P ^b  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b University of Wisconsin Madison   (United States)

^c Department of Biostatistics ^*  (United States)

Author keywords

Bivariate survival analysis; Clayton model; Dependent censoring; Semicompeting risks data

Indexed keywords

EFAVIRENZ; NELFINAVIR; NUCLEOSIDE DERIVATIVE;

ARTICLE; ASSAY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; METHODOLOGY; MODEL; MORBIDITY; MORTALITY; MULTICENTER STUDY; PARAMETER; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLE SIZE; SIMULATION; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0037383627     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(02)00307-0     Document Type: Article

References (26)

1. Fine J.P., Jiang H., Chappell R. On semi-competing risks data. Biometrika. 88:2001;907-919.
2. Copelan E.A., Biggs J.C., Tutschka P.J.et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with Bu/Cy2. Blood. 78:1991;838-843.
3. Day R., Bryant J., Lefkopoulou M. Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic indicators. Biometrika. 84:1997;45-56.
4. Tsiatis A.A. A nonidentifiability aspect of the problem of competing risks. Proc Nat Acad Sci. 72:1975;20-22.
5. Peterson A.V. Bounds for a joint distribution with subdistribution functions. application to competing risks Proc Nat Acad Sci. 73:1976;11-13.
6. Slud E.V., Rubinstein L.V. Dependent competing risks and summary survival curves. Biometrika. 70:1983;643-649.
7. Zheng M., Klein J.P. Estimates of marginal survival for dependent competing risks based on an assumed copula. Biometrika. 82:1995;127-138.
8. Emoto S.E., Matthews P.C. A Weibull model for dependent censoring. Ann Stat. 18:1990;1556-1577.
9. Link W.A. A model for informative censoring. J Am Stat Assoc. 84:1989;749-752.
10. Moeschberger M. Life tests under dependent causes of failure. Technometrics. 16:1974;39-47.
11. Andersen P.K., Borgan O., Gill R., Keiding N. Statistical models based on counting processes. 1993;Springer-Verlag, New York.
12. Lin D.Y., Robins J.M., Wei L.J. Comparing two failure time distributions in the presence of dependent censoring. Biometrika. 83:1996;381-393.
13. Clayton D.G. A model for association in bivariate life tables and its application to epidemiological studies of familial tendency in chronic disease epidemiology. Biometrika. 65:1978;141-151.
14. Oakes D. Bivariate survival models induced by frailties. J Am Stat Assoc. 84:1989;487-493.
15. Oakes D. A model for association in bivariate survival data. J R Stat Soc B. 44:1982;414-422.
16. Oakes D. Semiparametric inference in bivariate survival data. Biometrika. 73:1986;353-361.
17. Shih J.H. A goodness-of-fit test for association in a bivariate survival model. Biometrika. 85:1998;189-200.
18. Genest C., Rivest L.P. Statistical inference procedures for bivariate archimedean copulas. J Am Stat Assoc. 88:1993;1034-1043.
19. Albrecht M.A., Bosch R.J., Katzenstein D.A.et al. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection. N Eng J Med. 345:2001;398-407.
20. Schumacher M. Two-sample tests of Cramér-von Mises- and Kolmogorov-Smirnov-type for randomly censored data. Intl Stat Rev. 52:1984;263-281.
21. Bentzen S.M., Vaeth M., Pederson D.E., Overgaard J. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now! Intl J Radiat Oncol Biol Phys. 32:1995;1531-1534.
22. Caplan R.J., Pajak T.F., Cox J.D. In response to Bentzen et al. IJROBP. 32:1995;1531-1534. Intl J Radiat Oncol Biol Phys 1995;32:1547.
23. Denham J.W., Hamilton C.S., O'Brien P. Regarding actuarial late effect analyses. Bentzen et al., IJROBP 1995;32:1531-1534 and Caplan et al., IJROBP 1995;32:1547 Intl J Radiat Oncol Biol Phys. 35:1996;197.
24. Caplan R.J., Pajak T.F., Cox J.D. In response to Dr. Denham et al. Intl J Radiat Oncol Biol Phys. 35:1996;1547.
25. Chappell R. Comment on the articles of Caplan et al. and Bentzen et al. Intl J Radiat Oncol Biol Phys. 36:1996;988-999.
26. Keiding N., Filiberti M., Esbjerg S., Robins J.M., Jacobsen N. The graft versus leukemia effect after bone marrow transplantation. a case study using structural nested failure time models Biometrics. 55:1999;23-28.